0910-AB26 200310 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Blood Initiative Other Significant Previously Published in The Unified Agenda Proposed Rule Stage Undetermined No 21 CFR 600 21 CFR 601 21 CFR 606 21 CFR 607 21 CFR 610 21 CFR 630 21 CFR 640 21 CFR 660 21 CFR 680 21 USC 321 21 USC 331 21 USC 351 to 353 21 USC 355 21 USC 360 21 USC 371 21 USC 374 42 USC 216 42 USC 262 42 USC 263 42 USC 263a 42 USC 264 No 0910-AE89 Revisions to the Requirements Applicable to Blood, Blood Components, and Source Plasma 0910-AF02 Plasma Derivatives and Similar Recombinant-Based Products; Requirements for Notification of Recalls and Withdrawals 0910-AE99 General Requirements for Blood, Blood Components, and Plasma Derivatives; Notification of Deferred Donors 0910-AE95 Albumin (Human), Plasma Protein Fraction (Human) and Immune Globulin (Human); Revision of Requirements 0910-AE98 Requirements for Testing Human Blood Donors for Evidence of Infection Due to Communicable Disease Agents 0910-AF00 Regulations for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use 0910-AE96 Revisions to Labeling and Storage Requirements for Blood and Blood Components, Including Source Plasma No Businesses None No NA Not Collected 0910-AB76 Related to Paula McKeever S. 0910 Food and Drug Administration FDA 301 827-1520 301 443-9718 paula.mckeever@fda.hhs.gov Suite 200N (HFM-17), Office of the Commissioner, Office of Critical Path Programs, 5600 Fishers Lane, Room 14B-45, Rockville MD 20857-0001